Adicet Bio, Inc.

Listed Company
ACETCIK 0001720580NasdaqNon-AcceleratedSmaller ReportingPharmaceutical PreparationsDelawareFY ends Dec 26
Period
FY 2025
Revenue
—
Net Income
$-116.80M
Total Assets
—
Equity
—
Shares Out
9.35M
Op. Cash Flow
$-95.25M
ACET$8.10−32.21% · past yearDBEQ Basic
Daily closing prices

Business

Adicet Bio, Inc. is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies to treat autoimmune diseases and cancer. It develops “off-the-shelf” engineered gamma delta CAR T cell product candidates, including lead programs ADI-001 (anti‑CD20) for B‑cell mediated autoimmune diseases and ADI-270 (anti‑CD70) for renal cell carcinoma, plus discovery and preclinical programs. Its activities span clinical development, cGMP manufacturing and process scale-up, intellectual property and strategic collaborations. It targets patients in the United States, Europe, China, Japan and other global markets through clinical trials, CDMO partnerships and cryopreserved off‑the‑shelf distribution.

Summary from filing dated 2025-03-06

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue—
Net income$-116.80M
Total assets—
Total liabilities—
Stockholders' equity—
Operating cash flow$-95.25M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Adicet Bio, Inc.'s CIK number?

Adicet Bio, Inc.'s SEC CIK number is 0001720580 (1720580). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Adicet Bio, Inc.'s SEC filings?

All of Adicet Bio, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Adicet Bio, Inc. last report earnings?

Adicet Bio, Inc. (ACET) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001720580-26-000036). This is Adicet Bio, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Adicet Bio, Inc.'s most recent earnings 8-K?

Adicet Bio, Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001720580-26-000036. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Adicet Bio, Inc.'s latest earnings 8-K →
Look up any company's CIK number →